The iShares U.S. Healthcare ETF (IYH) seeks to track the Dow Jones U.S. Health Care Index, which measures the performance of U.S. companies primarily engaged in healthcare services, pharmaceuticals, biotechnology, and medical devices. This sector-focused equity ETF provides targeted exposure to America's healthcare industry.
How It Works
IYH uses a passively managed, market-capitalization-weighted approach that mirrors its benchmark index composition. The fund holds healthcare stocks in proportion to their market value, with larger pharmaceutical and healthcare companies receiving higher allocations. Rebalancing occurs quarterly to maintain alignment with index changes and sector weightings. The ETF typically holds 60-80 healthcare companies spanning pharmaceuticals, biotechnology, medical devices, and healthcare services subsectors.
Key Features
- Pure-play healthcare sector exposure without dilution from other industries, ideal for targeted sector allocation strategies
- Includes both established pharmaceutical giants and innovative biotechnology companies for comprehensive healthcare industry coverage
- Managed by BlackRock with strong liquidity and tight bid-ask spreads for efficient trading execution
Risks
- This ETF can lose significant value during healthcare sector selloffs, potentially declining 20-30% when drug pricing concerns or regulatory changes emerge
- Concentrated sector exposure means poor performance in one healthcare subsector can disproportionately impact the entire fund's returns
- Healthcare stocks face unique regulatory risks from FDA approvals, patent expirations, and government healthcare policy changes affecting profitability
Who Should Own This
Best suited as a satellite holding (5-15% of equity allocation) for investors with medium-to-high risk tolerance seeking healthcare sector exposure over 3+ year periods. Appropriate for those wanting to overweight healthcare relative to broad market indices or capitalize on demographic trends like aging populations.